Consistent with the 2024 CDC DPRP Standards, organizations are required to submit a separate application for each delivery mode used to the CDC
Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) Lancet
Pagani, M., Pilati, S., Bertoli, G., Valsasina, B
3,417 adults randomized to cagrilintide 2.4 mg + semaglutide 2.4 mg, cagrilintide alone, semaglutide alone, or placebo for 68 weeks
To further elucidate the potential role of CD36 in PA-induced ferroptosis, we generated efficient stable-transfected cell lines overexpressing the CD36 protein from MCF-7 (MCF-7-CD36) and SUM-159 cells (SUM-159-CD36)
Broken dispensing container must not be consumed